許 藝瓊

Medicine & Life Sciences

1. Thyroid Neoplasms 100%
2. Papillary Thyroid Cancer 83%
3. Adenocarcinoma of Lung 76%
4. Neoplasms 56%
5. 1,6-Bis(4-(4-amino-3-hydroxyphenoxy)phenyl)diamantane 39%
6. Lung Neoplasms 37%
7. hydroxygenkwanin 35%
8. Mutation 32%
9. Genes 31%
10. Non-Small Cell Lung Carcinoma 28%
11. Genome 26%
12. Neoplasm Metastasis 25%
13. Growth 24%
14. Thyroid Gland 23%
15. Cell Movement 22%
16. Recurrence 22%
17. HCT116 Cells 21%
18. Survival 20%
19. 2,2-bis(4-(4-amino-3-hydroxyphenoxy)phenyl)adamantane 20%
20. Cell Cycle Checkpoints 19%
21. Gene Expression 19%
22. Apoptosis 17%
23. ErbB Receptors 17%
24. Caspase 3 16%
25. Parathyroid Hormone 16%
26. Atlases 15%
27. Meta-Analysis 15%
28. Retinoid X Receptor gamma 15%
29. sodium-iodide symporter 14%
30. Cell Line 14%
31. Leptin Receptors 13%
32. Mitochondria 13%
33. Papillary Thyroid Microcarcinoma 13%
34. Ferroptosis 13%
35. 2-Methoxyestradiol 12%
36. Momordica charantia 12%
37. Endoplasmic Reticulum Stress 12%
38. Anoikis 12%
39. integrin-linked kinase 12%
40. High-Throughput Nucleotide Sequencing 12%
41. Integrins 12%
42. Adiponectin Receptors 12%
43. Guanosine Monophosphate 12%
44. perchlorate 12%
45. Alleles 12%
46. Taiwan 12%
47. Mupirocin 11%
48. Pentose Phosphate Pathway 11%
49. thiocyanate 11%
50. Epithelial-Mesenchymal Transition 11%